Things aren’t improving for the FDA, as our series on how the agency handled fraudulent drug trial data continues.
Check out this new investigative package on the FDA’s tepid response to drug trial fraud. My colleague Charles Seife and I spent months researching the story of how drugs approved by a research firm in Texas were left on the market, even after the FDA determined the company had committed pervasive “egregious” violations of Good Laboratory Practice.
I’m proud to say that after working with Bob Woodward for most of the past year, I now have the opportunity to spend some time working for ProPublica. I had often wondered what my next step would be after finishing work on Bob’s book, and whether I would be able to find an organization whose values and commitment to solid journalism matched his. In ProPublica, I believe I have, and I’m really pleased to be associated with it.
The Price of Politics debuted on the New York Times Bestseller list at #2 this week. I spent six months working with Bob Woodward, helping research, write and edit the book. In a note at the beginning of the book, Bob wrote: “Rob…is one of the best natural editors and reporters I have ever worked with.”
Since February, I have been working as senior research assistant to Bob Woodward, helping to research and write a book scheduled for publication in September 2012. My freelance work, as a result, is on hold until early 2013.
With banks on the receiving end of a lot of public wrath these days, it might not seem to be the most opportune time to launch a new one. But a bank branding consultant in Oregon is pushing ahead anyway, with a unique – some might say strange – concept for a niche web-based financial institution.